Raubling, Germany

Adolf Bauer

This inventor holds 9 USPTO granted patents. Top assignees: Boehringer Ingelheim Gmbh, Diamalt Aktiengesellschaft. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adolf Bauer. Retrieved from https://idiyas.com/inventor/adolf-bauer-30oa44l2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Rosenheim, DE (1978)
  • Ingelheim am Rhein, DE (1976 - 1980)
  • Raubling, DE (1981 - 1988)

Company Filing History:


Years Active: 1976-1988

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Adolf Bauer

Introduction

Adolf Bauer is a notable inventor based in Raubling, Germany. He has made significant contributions to the field of pharmacology through his innovative inventions. With a total of nine patents to his name, Bauer has established himself as a key figure in the development of valuable chemical compounds.

Latest Patents

Among his latest patents are 4-amino-3-imidazolin-2-one and (2-methoxy-2-iminoethyl) urea. These compounds serve as valuable intermediates for the production of pharmacologically active compounds. The processes for preparing these compounds are crucial for advancing pharmaceutical research and development.

Career Highlights

Bauer has worked with prominent companies such as Boehringer Ingelheim GmbH and Diamalt Aktiengesellschaft. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in the industry.

Collaborations

Some of his notable coworkers include Karl-Heinz Weber and Peter Danneberg. Their collaborative efforts have further enhanced the impact of Bauer's inventions in the field.

Conclusion

Adolf Bauer's contributions to pharmacology through his patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new pharmacological compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…